Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-06-19

Clinical Trial Update: Tranexamic Acid in Reverse Total Shoulder Arthroplasty [Phase 2, Phase 3]

View source ↗

Summary

Results from Phase 2 and Phase 3 trials evaluating tranexamic acid to reduce blood loss during reverse total shoulder arthroplasty were completed and posted in …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TRANEXAMIC ACID (TRANEXAMIC ACID)

Snippet

Sponsor: Corewell Health East | Conditions: Shoulder Joint Disease, Complications; Arthroplasty | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2017-06-19